|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2001-12-12
|
|
pubmed:abstractText |
Intravenous tissue-type plasminogen activator (tPA) therapy using the National Institute of Neurological Disorders and Stroke criteria has been given with variable safety to less than 5% of the patients who have ischemic strokes nationwide. Our center is experienced in treating large numbers of stroke patients with intravenous tPA.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0003-9942
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2009-13
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11735774-Adult,
pubmed-meshheading:11735774-Aged,
pubmed-meshheading:11735774-Aged, 80 and over,
pubmed-meshheading:11735774-Brain Ischemia,
pubmed-meshheading:11735774-Cerebral Hemorrhage,
pubmed-meshheading:11735774-Cohort Studies,
pubmed-meshheading:11735774-Female,
pubmed-meshheading:11735774-Humans,
pubmed-meshheading:11735774-Injections, Intravenous,
pubmed-meshheading:11735774-Male,
pubmed-meshheading:11735774-Middle Aged,
pubmed-meshheading:11735774-Plasminogen Activators,
pubmed-meshheading:11735774-Retrospective Studies,
pubmed-meshheading:11735774-Stroke,
pubmed-meshheading:11735774-Texas,
pubmed-meshheading:11735774-Tissue Plasminogen Activator
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.
|
|
pubmed:affiliation |
Stroke Treatment Team, University of Texas-Houston Medical School, Box 7.044, 6431 Fannin St, Houston, TX 77030, USA. james.c.grotta@uth.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
